Product & Pricing Regulation
IRDAI's File-&-Use / Use-&-File regime governing which products and prices an insurer can take to market.
Why you care
An insurer can't just invent a product and price it however it likes. IRDAI decides what can go to market and how much prior approval it needs. Loosen that regime and insurers can react to claims faster; tighten it and prices get stuck even when the risk has clearly changed.
Run the numbers
Under File-&-Use, a product waits for the regulator's nod before launch; under Use-&-File, the insurer can launch first and file after (illustrative — confirm current scope). The lighter the regime, the faster an insurer can fix an under-priced line and restore rate adequacy.
Where this goes
Product regulation sets how freely price can move, so it governs whether rate adequacy is even reachable — a rigid regime can trap prices below cost. On the life side, it decides which of the product-mix options an insurer can design and sell.
Why you care
Product and pricing regulation is IRDAI's control over what insurance products an insurer may sell and how much freedom it has to set the price. In India this runs through the File-&-Use and Use-&-File regimes. Either a product must be cleared by the regulator before it goes on sale, or the insurer can launch it and file the paperwork afterwards.
This matters because it sets the speed limit on pricing. Insurance is a business where the right price keeps changing — claims inflation, new medical costs, a run of catastrophes. An insurer's ability to respond depends on how tightly the regulator holds the approval process. A heavy File-&-Use regime protects customers from reckless or unfair products, but it can also leave prices stuck below cost while approvals grind through, quietly manufacturing underwriting losses. A lighter Use-&-File regime lets insurers adjust faster and keep rates adequate, at the cost of more after-the-fact scrutiny. IRDAI has been shifting parts of the market toward Use-&-File to give insurers more room, precisely because pricing agility is what keeps a book solvent. For anyone in product or pricing, this regime is the frame inside which every rate decision has to fit.
Run the numbers
Take an insurer whose health book is running hot — medical inflation has pushed claims above the price it charged last year. It wants to reprice.
- Under File-&-Use: it must file the revised product and wait for IRDAI clearance before selling at the new rate. Through that gap, it keeps writing at the old, now-inadequate price.
- Under Use-&-File: it can implement the corrected price and file afterwards, closing the rate adequacy gap much faster.
Same claims problem, very different speed of fix (illustrative). The regulatory regime doesn't set the price, but it sets how quickly a wrong price can be made right — and in insurance, that lag is measured in underwriting losses. The same regime also decides which product designs are permitted at all, which is where it reaches into the life side of the market.
Where this goes
Product regulation governs how freely price can move, so it sits directly upstream of rate adequacy. A rigid regime can trap an insurer selling below cost, while a lighter one lets it correct quickly. On the life side, the same regime decides which of the life product mix categories — Par, Non-Par, ULIP, Protection — an insurer can build and market. That in turn shapes where its margins come from. It is the regulator's hand on both the price and the product itself.